Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F. Hoffmann-La Roche & Co. AktiengesellschaftfiledCriticalF. Hoffmann-La Roche & Co. Aktiengesellschaft
Priority claimed from EP81109200Aexternal-prioritypatent/EP0051819B1/en
Application grantedgrantedCritical
Publication of ATE11766T1publicationCriticalpatent/ATE11766T1/en
6-PHENOXIMETHYL-4-HYDROXITETRAHYDROPYRAN-2-ONER, FOERFARANDE FOER DERAS FRAMSTAELLNING, DERAS ANVAENDNING SOM LAEKEMEDEL PHARMACEUTICAL PRODUCT AND CHARACTERISTICS.
PHENYLIMINOTHIAZOLINE DERIVATIVES, THEIR PRODUCTION AND INTERMEDIATE PRODUCTS FOR THEM, PHARMACEUTICAL PREPARATIONS CONTAINING THEM AND THEIR PRODUCTION.
GONADOLIBERINDERIVAT SOM INNEHAOLLER EN AROMATISK AMINOKARBOZYLSYRA I POSITION 6, PHARMACEUTICAL AND VETERINARY PREPARATIONS INNEHAOLLANDE DESSA OCH FOERFARANDE FOER FRAMSTAELLNING DAERAV.